Safety of medical therapy in patients with chronic kidney disease and end-stage renal disease.
about
Prescribing for patients on dialysisMaintaining safety in the dialysis facilityAdverse safety events in patients with Chronic Kidney Disease (CKD).American Society of Nephrology quiz and questionnaire 2014: acid-base and electrolyte disorders.Multiple medication (polypharmacy) and chronic kidney disease in patients aged 60 and older: a pharmacoepidemiologic perspective.Interspecies scaling of urinary excretory amounts of nine drugs belonging to different therapeutic areas with diverse chemical structures - accurate prediction of the human urinary excretory amounts.Inflammation down-regulates CYP3A4-catalysed drug metabolism in hemodialysis patients.
P2860
Q26752999-B5512F7F-F10F-4FE4-B165-6A0E00D65CBCQ26861568-EB0649B4-93A7-4DF9-8B35-D8A959B91355Q30245199-F60CEF0D-6DDD-4933-9E74-1234D6B7D787Q30300902-AF3015C5-0A57-4C85-95CA-FB43E4DE4935Q39965018-8CA39827-75AC-4484-AE44-981CA35EAC03Q46561449-5D9FA9CF-8E24-469F-B6EF-BAD7B8BE810DQ55439721-061C8801-732E-446B-956A-0F0023F707B6
P2860
Safety of medical therapy in patients with chronic kidney disease and end-stage renal disease.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Safety of medical therapy in p ...... e and end-stage renal disease.
@en
type
label
Safety of medical therapy in p ...... e and end-stage renal disease.
@en
prefLabel
Safety of medical therapy in p ...... e and end-stage renal disease.
@en
P1476
Safety of medical therapy in p ...... se and end-stage renal disease
@en
P2093
Matthew R Weir
P304
P356
10.1097/01.MNH.0000444912.40418.45
P577
2014-05-01T00:00:00Z